Skip to main content

Table 2 Results of the pairwise comparisons of individual hepatic fibrosis stages with respect to log2 MFAP4 values after significant ANOVA result

From: Evaluation of the biomarker candidate MFAP4 for non-invasive assessment of hepatic fibrosis in hepatitis C patients

Comparisona Differenceb Lower boundc Upper boundc p valued
F1–F0 0.1924 −0.1114 0.4962 0.4144
F2–F0 0.4386 0.1188 0.7584 0.0018
F3–F0 1.1168 0.7351 1.4984 3.43E−10
F4–F0 1.4277 1.0461 1.8092 3.43E−10
F2–F1 0.2462 −0.0287 0.5211 0.1036
F3–F1 0.9244 0.5796 1.2693 3.51E−10
F4–F1 1.2353 0.8903 1.5802 3.43E−10
F3–F2 0.6782 0.3191 1.0373 3.280E−6
F4–F2 0.9891 0.6300 1.3482 3.45E−10
F4–F3 0.3109 −0.1042 0.7260 0.2438
  1. aPairwise comparison between individual fibrosis stages
  2. bEstimated difference between true mean values of individual groups (log2 U/ml)
  3. cUpper respectively lower bound of the 95 % confidence interval of difference (log2 U/ml)
  4. dAdjusted p value according to Tukey’s‚ honest significant difference’ post hoc test